Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Seasonal Influenza Market?

In recent times, the size of the seasonal influenza market has experienced rapid expansion. It’s predicted to increase from $8.41 billion in 2024 to $9.85 billion in 2025, showcasing a compound annual growth rate (CAGR) of 17.1%. Factors that have contributed to the growth during the historical period include a higher prevalence of influenza, an expanding elderly population, an uptick in infectious and chronic diseases, an escalating burden of illnesses related to influenza, and an increase in respiratory infections.

Expect a swift expansion in the seasonal influenza market size in the upcoming years, as it’s projected to reach $18.39 billion in 2029, boasting a compound annual growth rate (CAGR) of 16.9%. The expected growth during the forecast period can be credited to factors such as the growing demand for oral medication solutions, the rise in research and development activities, increased rates of vaccination, enhancement in healthcare infrastructure, and the increased need for retail pharmacies. Key trends to watch for during this period include improvements in treatment and technology, breakthroughs in vaccine and mRNA technology, along with advancements in digital health solutions for monitoring and diagnosis.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21285&type=smp

Which Industry Forces Are Driving The Seasonal Influenza Market Forward?

The growing occurrence of respiratory infections is anticipated to drive the advancement of the seasonal influenza market. Respiratory infections, which are diseases triggered by viruses or bacteria impacting the respiratory system such as the sinuses, throat, airways, or lungs, are on the rise. Factors such as air pollution, changing weather conditions, diminished immune reactions, and the quick spread of viruses in congested or poorly aired areas are contributing to this increase. Seasonal flu treatments aid in preventing or lessening the harshness of these respiratory infections in numerous ways, mainly by attacking the flu virus and controlling symptoms that may lead to other infections. For example, in October 2024, the UK Health Security Agency, a government agency in the UK, reported that the instance of tuberculosis (TB) (a respiratory infection prompted by the bacterium Mycobacterium tuberculosis) cases saw an annual increase of 10.7% in 2023 in England, escalating from 4,380 cases in 2022 to 4,850 cases. Consequently, these escalating respiratory infection figures will contribute to the development of the seasonal influenza market.

How Is The Seasonal Influenza Market Organized By Different Segments?

The seasonal influenzamarket covered in this report is segmented –

1) By Type: Influenza A Virus; Influenza B Virus; Influenza C Virus; Influenza D Virus

2) By Route Of Administration: Parenteral; Oral; Other Route Of Administrations

3) By Distribution Channel: Hospital; Government and institutional supply; Pharmacy; Online

4) By Treatment: Antiviral; Neuraminidase Inhibitors; Vaccination; Other Treatments

Subsegments:

1) By Influenza A Virus: Subtype H1N1; Subtype H3N2; Other Subtypes

2) By Influenza B Virus: Lineage Victoria; Lineage Yamagata

3) By Influenza C Virus: Seasonal C Virus; Non-seasonal C Virus

4) By Influenza D Virus: Animal-associated Influenza D

What Current And Upcoming Trends Are Shaping The Seasonal Influenza Market?

In the seasonal influenza market, key players are focusing on combination vaccines to strengthen immunity by targeting multiple virus strains, boosting vaccine efficacy and reducing vaccination frequency. Combination vaccines protect against several diseases or strains through a single injection, simplifying immunization schedules. For instance, in October 2023, US biotechnology company Moderna announced encouraging interim Phase 1/2 trial results for mRNA-1083, a combination vaccine targeting both influenza and COVID-19. Designed to improve compliance and convenience, this vaccine is being evaluated against standard flu vaccines such as Fluarix and Fluzone HD, as well as the Spikevax booster.

Who Are The Primary Market Leaders In The Seasonal Influenza Market?

Major companies operating in the seasonal influenza market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc, Merck KGaA, Moderna Inc., Boehringer Ingelheim International GmbH, Sinovac Biotech Ltd., Daiichi Sankyo Company Limited, CSL Limited, Genentech Inc., Shionogi & Co. Ltd., Emergent BioSolutions Inc., Novavax Inc., BioCryst Pharmaceuticals Inc., Bharat Biotech International Limited, Vaxart Inc., Inovio Pharmaceuticals Inc., SK bioscience Co. Ltd., Mitsubishi Tanabe Pharma Corporation, FluGen Inc., Altimmune Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/seasonal-influenza-global-market-report

How Do Regional Dynamics Influence The Seasonal Influenza Market Performance?

North America was the largest region in the seasonal influenza market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the seasonal influenza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21285&type=smp

Browse Through More Reports Similar to the Global Seasonal Influenza Market 2025, By The Business Research Company

Influenza Diagnostic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Influenza Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Virus Filtration Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/virus-filtration-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model